Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO ®) induced neutralizing antibody titers

Vaccine

Volumn 29, Issue 35, 2011, Pages 5925-5931

  Van Gessel, Yvonne ^a   Klade, Christoph S ^c   Putnak, Robert ^b   Formica, Alessandra ^c   Krasaesub, Somporn ^a   Spruth, Martin ^c   Cena, Bruno ^c   Tungtaeng, Anchalee ^a   Gettayacamin, Montip ^a   Dewasthaly, Shailesh ^c  

^a U S ARMY   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c INTERCELL AG   (Austria)

Author keywords

Correlation; Ixiaro; Japanese encephalitis; Protection; Vaccine

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EX VIVO STUDY; FEMALE; GENOTYPE; HUMAN; IMMUNITY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LETHAL DOSE; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SURVIVAL TIME; VACCINATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNIZATION, PASSIVE; JAPANESE ENCEPHALITIS VACCINES; MALE; MICE; MICE, INBRED ICR; NEUTRALIZATION TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79960744859     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.062     Document Type: Article

References (30)

1. Fulmali P.V., Sapkal G.N., Athawale S., Gore M.M., Mishra A.C., Bondre V.P. Introduction of Japanese encephalitis virus genotype I, India. Emerg Infect Dis 2011, 17:319-321.
2. Centers for disease control and prevention (CDC) Japanese encephalitis in two children-United States 2010. MMWR 2011, 60:276-278.
3. Halstead S.B., Tsai T.F. Japanese encephalitis vaccines. Vaccine 2004, 919-958. Elsevier Inc., USA. 4th ed. S.A. Plotkin, W.A. Orenstein (Eds.).
4. Takahashi H., Pool V., Tsai T.F., Chen R.T. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. Vaccine 2000, 18:2963-2969.
5. Halstead S.B., Thomas S.J. Japanese encephalitis: new options for active immunization. Clin Infect Dis 2010, 50:1155-1164.
6. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001, 19:4557-4565.
7. Ixiaro (SPC) European Medicinal Agency, <> [website accessed 03.05.11]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000963/WC500037287.pdf.
8. Tauber E., Kollaritsch H., Korinek M., Rendi-Wagner P., Jilma B., Firbas C., et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007, 370:1806-1808.
9. Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine 2000, 18(Suppl. 2):26-32.
10. Leake C.J., Burke D.S., Nisalak A., Hoke C.H. Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line. Am J Trop Med Hyg 1986, 35:1045-1050.
11. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
12. Tarone R.E., Ware J. On distribution-free tests for equality of survival distributions. Biometrika 1977, 64(1):156-160.
13. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17:1055-1065.
14. Qin L., Gilbert P.B., Corey L., McElrath M.J., Self S.G. A framework for assessing immunological correlates of protection in vaccine trials. JID 2007, 196:1304-1312.
15. Plotkin S. Correlates of vaccine-induced immunity. Clin Infect Dis 2008, 47:401-409.
16. Coffin S.E., Moser C.A., Cohen S., Clark H.F., Offit P.A. Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice. J Virol 1997, 71:7851-7856.
17. Konishi E., Ajiro N., Nukuzuma C., Mason P.W., Kurane I. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine 2003, 21:3675-3683.
18. Kumar P., Sulochana P., Nirmala G., Chandrashekar R., Haridattatreya M., Satchidanandam V., et al. Helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. J Infect Dis 2004, 189:880-891.
19. Oya A. Japanese encephalitis vaccine. Acta Paediatr Jpn 1988, 30:175-184.
20. Hasegawa H., Yoshida M., Kobayashi Y., Fujita Antigenic analysis of Japanese encephalitis viruses in Asia using monoclonal antibodies. Vaccine 1995, 13:1713-1721.
21. Beasley D.W.C., Lia L., Suderman M.T., Guirakhoo F., Trent D.W., Monath T.P., et al. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVaxTM-JE experimental vaccine. Vaccine 2004, 22:3722-3726.
22. Hombach J., Solomon T., Kurane, Jacobson J., Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 2005, 23:5205-5211.
23. Simmons M., Burgessa T., Lynch J., Putnak R. Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy. Virology 2010, 396:280-288.
24. 50 assays for Japanese encephalitis virus (JE) antibodies. Biologicals 2008, 36(2):111-116.
25. Wills M.R., Sil B.K., Cao J.X., Yu Z.X., Barrett D.T. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area. Vaccine 1992, 10:861-872.
26. Uchil P.D., Satchidanadam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg 2001, 65:242-251.
27. Tsarev S.A., Sanders M.L., Vaughn D.W., Innis B.L. Phylogenetic analysis suggests only on serotype of Japanese encephalitis virus. Vaccine 2000, 18:36-43.
28. Solomon T., Ni H., Beasley W.C., Ekkelenkamp M., Cardosa M.J., Barrett A.D.T. Origin and evolution of Japanese encephalitis virus in Southeast Asia. J Virol 2003, 77:3091-3098.
29. Ma S.P., Yoshida Y., Makino Y., Tadano M., Ono T., Ogawa M. Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am J Trop Med Hyg 2003, 69:151-154.
30. Zhang J.S., Zhao Q.M., Guo X.F., Zuo S.Q., Cheng J.X., Jia N., et al. PLoS One 2011, 6:e16418.